Deubiquitinase OTUB1 attenuates pathological cardiac hypertrophy by activating the AMPK signaling pathway.

Zhuang L, Xiong J, Wu Z, Zeng H, Cao Y, Yan X, Wu Y, Tong J

DOI: 10.1097/fjc.0000000000001890
Published: 2026 Oct 15
Container: Journal of cardiovascular pharmacology
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1097/fjc.0000000000001890,
  title = {Deubiquitinase OTUB1 attenuates pathological cardiac hypertrophy by activating the AMPK signaling pathway.},
  author = {Zhuang L and Xiong J and Wu Z and Zeng H and Cao Y and Yan X and Wu Y and Tong J},
  year = {2026},
  journal = {Journal of cardiovascular pharmacology},
  doi = {10.1097/fjc.0000000000001890},
  url = {https://doi.org/10.1097/fjc.0000000000001890}
}

RIS

TY  - JOUR
TI  - Deubiquitinase OTUB1 attenuates pathological cardiac hypertrophy by activating the AMPK signaling pathway.
AU  - Zhuang L
AU  - Xiong J
AU  - Wu Z
AU  - Zeng H
AU  - Cao Y
AU  - Yan X
AU  - Wu Y
AU  - Tong J
PY  - 2026
JO  - Journal of cardiovascular pharmacology
DO  - 10.1097/fjc.0000000000001890
UR  - https://doi.org/10.1097/fjc.0000000000001890
ER  -

APA

L, Z., J, X., Z, W., H, Z., Y, C., X, Y., Y, W., & J, T. (2026). Deubiquitinase OTUB1 attenuates pathological cardiac hypertrophy by activating the AMPK signaling pathway.. Journal of cardiovascular pharmacology. https://doi.org/10.1097/fjc.0000000000001890

Source records

pubmed · retrieved 2026-11-10T18:50:50.654Z
europe-pmc · retrieved 2026-11-10T18:50:50.653Z